1Birkedal -Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review[J]. Crit Rev Oral Biol Meal, 1993,4(2) : 197-250.
2Nagase H. Activation mechanisms of matrix metalloproteinases[ J]. Biol Chem, 1997,378(3-4) : 151-160.
3Denhardt DT, Feng B, Edwards DR, et al. Tissue inhibitor of metalloproteinases( TIMP, aka EPA ) : structure, control of expression and biological functions[J]. Pharmacol Ther, 1993,59(3) :329-341.
6He E, Keiser JA. Hepatosyte growth factor enhances MMP acti,Aty in human endothelial cells[J]. Biochem Biophys Res Commun,2000,272(3) :9(30-905.
7Rajavashisth TB,Liao JK, Galis ZS, et al. Inflammatory. c.vtokines and oxidited low density lipoproteins increase endothelial cell expression of membertane typel-matrix metalloproteinase[ J]. J Biol Chem, 1999,274(17) : 11924-11929.
8Yamashita A, Noma T, Nakazawa A, et al. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms [ J ]. World J Surg,2001,25(3) :259-265.
9Nishizuka Y. Studies and prospectives of the protein kinase C family for cellular regulation[J]. Cancer, 1989,63( 10):1892-1903.
10Zhu DL, Herembert T, Marche P. Increased proliferation of adventitial fibroblasts from spontaneously hypertensive rat aorta[J]. J Hypertens,1991,9(12) : 1161-1168.
2[1]Nagase H.Activation mechanis ms of matrix metalloproteinases.Biol Che m,1997,378:151-160.
3[2]Brew K,Dinakarpandian D,Nagase H.Tissu e inhibitors of metalloproteinases:evolu tion,structure and function.Biochim Biop hys Acta,2000,1477:267-283.
4[3]Rajavashisth TB,Xu XP,Jovinge S.Membra ne type 1 matrix metalloproteinase expre ssion in human atherosclerotic plaques:e vidence for activation by proinflammator y mediators.Circulation,1999,99:3103-310 9.
5[4]Fitzgerald M,Hayward IP,Thomas AC,et al.Matrix metalloproteinase c an facilitate the heparanase-induced pro motion of phenotype change in vascular s mooth muscle cells.Atherosclerosis,1999, 145:97-106.
6[5]Pasterkamp G,Schoneveld AH,Hijnen DJ,[ WTBZ〗et al.Atherosclerotic arteria l remodeling and the localization of mac rophages and matrix metalloproteases 1,2 and 9 in the human coronary artery.Athe rosclerosis,2000,150:245-253.
7[6]Lee RT,Schoen FJ,Loree HM,et al[ WTBZ〗.Circumferential stress and matrix metalloproteinase 1 in human coronary at herosclerosis.Implications for plaque ru pture.Arterioscler Thromb Vasc Biol,1996 ,16:1070-1073.
8[7]Sukhova GK,Schonbeck U,Rabkin E,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in v ulnerable human atheromatous plaques.Cir culation,1999,99:2503-2509.
9[8]Lijinen HR,Soloway P,Collen D.Tissure inhibitor of matrix metalloproteinase-1 impairs arterial neointima formation aft er vascular injure in mice.Cir Res,1999, 85:1186-1191.
10[9]Fukumoto Y,Libby P,Rabkin E.Statins al ter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic ra bbits.Circulation,2001,103:993-999.
9Zettler ME, Prociuk MA, Austria JA, et al. oxLDL stimulates cell proliferation through a general induction of cell cycle proteins, Am J Physiol Heart Circ Physiol, 2003, 284(2): H644- H653.
10Kugiyama K, Kerns S, Morrisett JD, et al. Impairment of endothelium- dependent arterial relaxation by lysolecithin in modified low-density lipoproteins, Nature, 1990, 344(6262): 160-162.
